We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

50 hedge funds and large institutions have $147M invested in Karuna Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

32% more funds holding

Funds holding: 38 → 50 (+12)

12% less capital invested

Capital invested by funds: $167M → $147M (-$19.6M)

56% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 16

Holders
50
Holders Change
+12
Holders Change %
+31.58%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
7
Reduced
16
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WT
Wellcome Trust
United Kingdom
+$24.6M
2
Fidelity International
Fidelity International
Bermuda
+$7.24M
3
BlackRock
BlackRock
New York
+$5.32M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.06M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$16.3M
2
PHS
PFM Health Sciences
California
-$7.04M
3
VC
Vivo Capital
California
-$6.51M
4
MIM
Monashee Investment Management
Massachusetts
-$2.2M
5
Goldman Sachs
Goldman Sachs
New York
-$1.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
HSBC Holdings
26
HSBC Holdings
United Kingdom
$509K +$606K +31,168 New
TD Asset Management
27
TD Asset Management
Ontario, Canada
$374K +$446K +22,931 New
FCM
28
Flinton Capital Management
Pennsylvania
$317K -$19.8K -1,020 -5%
TAM
29
Tyers Asset Management
Texas
$261K -$16.3K -840 -5%
MS
30
Maven Securities
Jersey
$213K -$232K -11,920 -48%
NA
31
Neuburgh Advisers
California
$205K -$12.8K -660 -5%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$190K +$226K +11,651 New
DCM
33
DAFNA Capital Management
California
$183K +$23.2K +1,192 +12%
MCIM
34
Meadow Creek Investment Management
Georgia
$149K -$9.33K -480 -5%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$116K +$139K +7,135 New
CSS
36
Cubist Systematic Strategies
Connecticut
$93K +$111K +5,703 New
Wells Fargo
37
Wells Fargo
California
$78K +$92.7K +4,768 New
UBS Group
38
UBS Group
Switzerland
$57K +$68K +3,498 New
AIG
39
American International Group
New York
$47K +$56.2K +2,892 New
Bank of America
40
Bank of America
North Carolina
$42K +$42.1K +2,167 +484%
Barclays
41
Barclays
United Kingdom
$37K +$43.9K +2,258 New
JP Morgan Chase
42
JP Morgan Chase
New York
$32K -$487K -25,040 -93%
Morgan Stanley
43
Morgan Stanley
New York
$32K +$38.1K +1,959 New
SO
44
STRS Ohio
Ohio
$19K +$23.3K +1,200 New
Victory Capital Management
45
Victory Capital Management
Texas
$17K +$19.7K +1,014 New
Legal & General Group
46
Legal & General Group
United Kingdom
$12K +$14.1K +727 New
RCM
47
Riverhead Capital Management
Delaware
$10K – – –
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$9.45K +$11.3K +579 New
AIP
49
Ameritas Investment Partners
Nebraska
$6K +$7.38K +380 New
Citigroup
50
Citigroup
New York
$3K -$220K -11,297 -98%
1
2
3

KRTX Hedge Fund Activity: Q3 2019 in Review

50 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q3 2019, worth a combined $147M — down 12% from $167M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KRTX positions and 12 closed out — a net gain of 12 holders — while 7 added to existing stakes and 16 trimmed.

The largest buyer was Wellcome Trust, opening a new position worth an estimated $24.6M. The largest seller was Eventide Asset Management, cutting an estimated $16.3M.

  • 50 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q3 2019, up from 38 in Q2 2019.
  • Funds reported $147M of Karuna Therapeutics, Inc. Common Stock stock for Q3 2019, down 12% quarter-over-quarter.
  • 24 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q3 2019 and 12 closed out, a net change of +12 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q3 2019 was Wellcome Trust, an estimated $24.6M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q3 2019 was Eventide Asset Management, an estimated $16.3M sold.

Based on aggregated 13F filings for Q3 2019.